Questions aim low, answers land high: the dialogue keeps correcting expectations upward with facts already in hand
The model's full reasoning — Q1 2017 call → NO我们根据指令分析电话会议中提问者与管理层之间的错位。关键动态:提问者的问题基于较低或更谨慎的预期,而管理层用已经发生的具体事实进行向上修正。 检查问题: - 关于SPINRAZA的支付方覆盖范围:提问者询问支付方政策是否改变,管理层将问题转给Biogen,但暗示数据可用。这并非明显的向上修正。 - 关于CAG重复和竞争对手:提问者暗示Ionis的靶向可能处于劣势,管理层表示有信心,但未提供具体事实。 - 关于NURTURE研究中的症状前患者:提问者询问报销情况,管理层表示预期会同意,但未提供具体事实。 - 关于FPL研究:提问者询问招募情况,管理层表示进展顺利,但未提供具体事实。 - 关于SOD1:提问者询问时间线和监管指导,管理层表示数据明年,与FDA有对话,但未提供具体事实。 - 关于NEURO-TTR:提问者询问时间线和心脏亚组,管理层拒绝提供细节。 - 关于volanesorsen的AdCom:提问者询问,管理层表示为时过早。 - 关于Huntington's:提问者询问时间线和成功标准,管理层表示测量CSF蛋白减少,时间线年底或明年初。 没有出现提问者基于较低预期而管理层用具体已发生事实进行向上修正的反复模式。问题大多是询问时间线、细节或未来计划,管理层回答谨慎或转给合作伙伴。没有明显的“提问者低于业务”的动态。管理层没有反复用具体运营事实纠正谨慎的框架。因此,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| FWONK | Formula One Group | Q1 2024 | 2024-05-08 | C+ |
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| PDS | Precision Drilling Corporation | Q1 2024 | 2024-04-25 | B |
| GL | Globe Life Inc. | Q1 2024 | 2024-04-23 | F |
| GIII | G-III Apparel Group, Ltd. | Q4 2024 | 2024-03-14 | C |
| NICE | NICE Ltd. | Q4 2023 | 2024-02-22 | B+ |
| EGP | EastGroup Properties, Inc. | Q4 2023 | 2024-02-08 | B |
| DASH | DoorDash, Inc. | Q3 2023 | 2023-11-01 | C+ |
| SITM | SiTime Corporation | Q2 2023 | 2023-08-02 | C+ |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| SLF | Sun Life Financial Inc. | Q1 2023 | 2023-05-12 | B |
| SPIR | Spire Global, Inc. | Q1 2023 | 2023-05-10 | B |
| KE | Kimball Electronics, Inc. | Q3 2023 | 2023-05-06 | C+ |
| SBRA | Sabra Health Care REIT, Inc. | Q1 2023 | 2023-05-04 | B |
| BRX | Brixmor Property Group Inc. | Q1 2023 | 2023-05-02 | A |
| TACT | TransAct Technologies Incorporated | Q4 2022 | 2023-03-08 | A |
| DKS | DICK'S Sporting Goods, Inc. | Q4 2022 | 2023-03-07 | B |
| TOST | Toast, Inc. | Q4 2022 | 2023-02-16 | C+ |
| ADPT | Adaptive Biotechnologies Corporation | Q4 2022 | 2023-02-14 | C+ |
| ADM | Archer-Daniels-Midland Company | Q4 2022 | 2023-01-26 | C+ |
| HBAN | Huntington Bancshares Incorporated | Q4 2022 | 2023-01-20 | B |
| UAL | United Airlines Holdings, Inc. | Q4 2022 | 2023-01-18 | B |
| ICL | ICL Group Ltd | Q3 2022 | 2022-11-09 | B+ |
| SYY | Sysco Corporation | Q1 2023 | 2022-11-01 | C+ |
| FLR | Fluor Corporation | Q2 2022 | 2022-08-05 | D |
| CRL | Charles River Laboratories International | Q2 2022 | 2022-08-03 | C |
| HLNE | Hamilton Lane Incorporated | Q1 2023 | 2022-08-02 | C+ |
| SGRY | Surgery Partners, Inc. | Q2 2022 | 2022-08-02 | B+ |
| IT | Gartner, Inc. | Q2 2022 | 2022-08-02 | A |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| CME | CME Group Inc. | Q2 2022 | 2022-07-27 | B |
| PRGS | Progress Software Corporation | Q2 2022 | 2022-06-28 | B+ |
| KFY | Korn Ferry | Q4 2022 | 2022-06-22 | B |
| BHF | Brighthouse Financial, Inc. | Q1 2022 | 2022-05-10 | C |
| VVV | Valvoline Inc. | Q1 2022 | 2022-02-09 | C+ |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| MD | Pediatrix Medical Group, Inc. | Q3 2021 | 2021-10-28 | B |
| LOPE | Grand Canyon Education, Inc. | Q2 2021 | 2021-08-08 | C |
| T | AT&T Inc. | Q3 2018 | 2018-10-24 | C+ |
| STM | STMicroelectronics NV | Q3 2018 | 2018-10-24 | C+ |
| TMHC | Taylor Morrison Home Corporation | Q2 2018 | 2018-08-01 | B |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| KIM | Kimco Realty Corporation | Q2 2018 | 2018-07-26 | B+ |
| HPE | Hewlett Packard Enterprise Company | Q2 2018 | 2018-05-22 | B+ |
| LAUR | Laureate Education, Inc. | Q1 2018 | 2018-05-13 | B+ |
| SATS | EchoStar Corporation | Q1 2018 | 2018-05-10 | C+ |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| KRG | Kite Realty Group Trust | Q1 2018 | 2018-04-26 | C+ |
| AVT | Avnet, Inc. | Q2 2018 | 2018-01-25 | B |
| RACE | Ferrari N.V. | Q3 2017 | 2017-11-02 | C+ |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| SNA | Snap-on Incorporated | Q3 2017 | 2017-10-19 | B |
| LIND | Lindblad Expeditions Holdings, Inc. | Q2 2017 | 2017-08-06 | C |
| CCOI | Cogent Communications Holdings, Inc. | Q2 2017 | 2017-08-03 | B |
| LEA | Lear Corporation | Q2 2017 | 2017-07-26 | B+ |
| DHR | Danaher Corporation | Q1 2017 | 2017-04-20 | B |
| CAG | Conagra Brands, Inc. | Q2 2017 | 2016-12-22 | C+ |
| MAT | Mattel, Inc. | Q3 2016 | 2016-10-19 | C |
| CGNX | Cognex Corporation | Q2 2016 | 2016-08-01 | A |
| GOGO | Gogo Inc. | Q1 2016 | 2016-05-06 | C+ |
| DD | DuPont de Nemours, Inc. | Q1 2016 | 2016-04-26 | B+ |
| HPP | Hudson Pacific Properties, Inc. | Q4 2015 | 2016-02-25 | C |
| HD | The Home Depot, Inc. | Q4 2015 | 2016-02-23 | A |
| JHX | James Hardie Industries plc | Q3 2016 | 2016-02-19 | B+ |
GOGO · Q1 2016 → YESThe question is about whether there's a clear, recurring mismatch where analysts assume a more modest/cautious/troubled version, and management corrects UPWARD with things already happening. YES The analysts' questions repeatedly frame the business around cautious or risk-oriented assumptions—such as ARPA trajectory concerns amid competition, cash and liquidity needs, potential sentiment issues with the Gogo brand, and competitive pressures from Panasonic—while management consistently corrects upward by citing concrete, already-realized facts: record revenues, 2Ku now in service on AeroMexico and IAG, over 1,000 planes awarded, Delta increases, install records, and backlog progress already achieved. This pattern repeats across multiple exchanges, with management pointing to present-tense operational realities that exceed the cautious premises embedded in the questions.
LAUR · Q1 2018 → YESThe question is about whether there's a clear, recurring mismatch in level between what the questioners assume and what management reports, with the mismatch running UPWARD. Analysts think more modest...YES The transcript shows a clear recurring mismatch running upward. Analysts repeatedly probe cautious angles—Chile as a potential end rather than final ruling, Brazil FIES exposure as a risk, margin phasing and guidance including divestitures, Turkey as needing update, FCF not raised despite Chile, leverage post-St. Augustine, and Accelerator 2.0 health sciences—framing the business around lingering uncertainties or modest upside.
JHX · Q3 2016 → YESThe question is about whether there's a clear, recurring mismatch where analysts assume a more modest/cautious/troubled version, and management corrects UPWARD with concrete things already happening. ...NO The transcript shows analysts probing for signs of weakness or slowdowns (seasonal margins, destocking, Europe performance, PDG pickup, volumes vs targets), but management repeatedly corrects upward with concrete current facts: strong Q3 margins (2.6 points better), no destocking, plants running well, costs controlled, 12% volume growth, Europe already through the one-off, and inventory normalized.